Chewy Raised Its Forecast — and the Stock Fell 11%

Chewy raised its full-year sales forecast on September 9 — and the stock promptly fell 11%, to just over $20.

That gap is the whole story. Headlines tell you the online pet retailer upgraded its outlook. The market read the quarter as a miss. Both can't be right, so the useful question is what actually happened under the surface.

The quarter looked good on paper

Chewy reported fiscal second-quarter sales up 7.3% to $3.33 billion, essentially in line. Adjusted earnings of $0.36 matched estimates exactly. Profit, by one measure, looked genuinely strong: adjusted EBITDA hit $226.7 million, a 6.8% margin, up 90 basis points from the year-earlier quarter and well ahead of the company's own 6.3%–6.4% guide.

Stripped of acquisitions, though, organic growth was just 5.7%. And beneath the headline earnings was the number that broke the stock: free cash flow fell 15.5% year over year to $89.5 million, from $106 million, as capital spending jumped 71% to $47.9 million on integration costs for the veterinary and equestrian businesses Chewy bought.

That is the reverse of the story investors had been telling. The stock had run up more than 15% in the month before earnings, on a thesis that Chewy had quietly turned into a cash machine — a recurring-revenue pet business with fattening margins spitting out free cash flow at a price the market hadn't caught up to. Options implied a roughly 10% post-earnings swing. A decently sized group was positioned for a beat.

They got in-line earnings and a cash-flow decline. Outcome: an 11% drawdown in a session when the S&P 500 fell 0.4%, and Petco dropped 6% while Freshpet barely moved. This was Chewy-specific — the market punishing this stock's cash story, not the whole sector.

The "record" margin needs a footnote

The 6.8% adjusted EBITDA margin looks like the engine doing its job. Look closer. CFO Chris Deppe put roughly $15 million of the quarter's profit upside down to timing and discrete items — tariff refunds arriving early, rebate timing shifts, gift card breakage, inventory adjustments. Strip those out and the underlying expansion is real but far more modest than the round number implies.

Management made the honest admission that goes with it: the company is not assuming any meaningful recovery in pet spending for the rest of the fiscal year. Consumers are still buying dog food and medications — core essentials — but pulling back on discretionary treats and toppers. Pricing power is described as "very low" for 2026. Fuel is a mid-single-digit millions headwind. This is a company managing a soft, price-competitive market, not one riding a tailwind.

The "upgrade" is smaller than it sounds

Yes, Chewy raised guidance. Full-year sales now target $13.46–$13.57 billion, with the adjusted EBITDA margin range lifted to 6.7%–6.8%, which implies roughly $912 million in adjusted EBITDA at the midpoint.

But read the arc. In June, Chewy cut its full-year sales outlook to $13.40–$13.55 billion after the consumer weakened late in the first quarter — and the stock fell then too. That cut clawed back part of the $13.60–$13.75 billion forecast it had issued in March, which originally sent shares up. Wednesday's raise claws back only a slice of June's cut. The new range still sits below where the year started, and organic growth of 5.5%–6.3% is firmly mid-single-digit.

So a superficial read says "upgraded forecast, good news." The data says the company spent the year walking its own sales target down and has now reversed maybe a third of the damage, while telling you demand won't recover.

Where the bet actually rests

Chewy's durable asset is the thing that got better this quarter, not the thing that filled headlines. Autoship — the subscription-like program that auto-ships food and supplies on a schedule — grew 9.3% to $2.82 billion and reached 84.6% of all net sales, up from 83% a year ago. Active customers rose 3.8% to 21.7 million, and net sales per customer ticked up to $602. In a world of undifferentiated, price-competitive pet supplies, that locked-in recurring relationship is the scarce, defensible layer of the business, and it's gaining share at roughly two to three times the broader category's rate.

The company is also buying its own stock — $200 million of repurchases in the quarter, with management saying shares look undervalued — and it ended the period with more than $1 billion in liquidity.

But all of that only matters if the recurring revenue actually converts to free cash flow. That is now the entire question. The bull case for Chewy rests on this equation: sticky autoship revenue plus margin leverage equals growing cash to buy back stock. Wednesday tested that equation and the cash half came up short. Management says the decline was "entirely timing-related" and still targets roughly 80% of net income converting to free cash flow for the full year. Jefferies called the veterinary and equestrian buildout "sensible" while conceding the payoff timeline is uncertain.

That ~80% conversion target is the falsifiable claim the bull thesis now hangs on. If free cash flow recovers in the next quarters and the 80% conversion shows up, then today's 11% haircut was the market overreacting to a genuinely lumpy quarter, and a stock trading roughly half its 52-week high got cheaper for a timing artifact. If the cash doesn't return, then the "record" margin was partly propped up by non-recurring items, the decelerating top line is the real trend, and the market was right to sell into the raised forecast.

Six months ago the argument for Chewy was that it was a mispriced growth stock. The evidence this quarter says that title is aging. What's left is a narrower, more honest proposition: a mid-single-digit-growth retailer with a sticky recurring base, real but flattered margins, and a cash-conversion promise it now has to prove with actual free cash flow. The upgraded forecast was real. It just wasn't the news the market heard.